Market Research Logo

50 Key Biopharmaceutical and Biotechnology Companies

  • Executive Summary
    • Introduction
    • Scope and Methodology
    • Market Summary
      • Table Summary: Top 10 of the Top 50 Biotechnology Companies by Biologic Revenues 2017 ($ billions)
  • Introduction
    • Biopharmaceuticals and Biotherapeutics
      • Biopharmaceuticals
      • Biotechnology
      • Areas of Treatment for Biopharmaceuticals
    • Regulations for Biopharmaceuticals
  • 50 Key Biopharmaceutical and Biotechnology Companies: Profiles
    • AbbVie
      • Table AbbVie Corporate Summary
      • Company Overview
        • Table Selected AbbVie Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table AbbVie (2015-2017) ($ millions)
    • Agilent Technologies Inc.
      • Table Agilent Corporate Summary
      • Company Overview
        • Table Agilent Regional Breakdown by %
      • Company Financials
        • Table Agilent (2015-2017) ($ millions)
    • Alexion Pharmaceuticals Inc
      • Table Alexion Corporate Summary
      • Company Overview
        • Table Alexion Regional Breakdown by %
        • Table Selected Alexion Biopharmaceutical Products
        • Table Selected Alexion Biopharmaceuticals in Development
      • Company Financials
        • Table Alexion (2015-2017) ($ millions)
    • Allergan plc
      • Table Allergan Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table Allergan (2015-2017) ($ millions)
    • Ambry Genetics
      • Table Ambry Genetics Corporate Summary
      • Company Overview
    • Amgen, Inc
      • Table Amgen Corporate Summary
      • Company Overview
        • Table Amgen Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Amgen Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Amgen (2015-2017) ($ millions)
    • AstraZeneca plc
      • Table AstraZeneca Corporate Summary
      • Company Overview
        • Table AstraZeneca Regional Breakdown by %
        • Table Selected Biopharmaceuticals Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table AstraZeneca (2015-2017) ($ millions)
    • Bayer AG
      • Table Bayer AG Corporate Summary
      • Company Overview
        • Table Bayer Regional Breakdown by %
        • Table Selected Bayer AG Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Bayer (2015-2017) ($ millions)
    • Berry Genomics Co Ltd.
      • Table Berry Genomics Corporate Summary
      • Company Overview
    • Biogen
      • Table Biogen Corporate Summary
      • Company Overview
        • Table Biogen Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Biogen (2015-2017) ($ millions)
    • BioMarin Pharmaceutical Inc
      • Table BioMarin Pharmaceutical Corporate Summary
      • Company Overview
        • Table BioMarin Regional Breakdown by %
        • Table Selected Biopharmaceuticals Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table BioMarin (2014-2017) ($ millions)
    • Bristol Myers Squibb
      • Table Bristol Myers Squibb Corporate Summary
      • Company Overview
        • Table BMS Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table BMS (2015-2017) ($ millions)
    • Celgene
      • Table Celgene Corporate Summary
      • Company Overview
        • Table Celgene Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Celgene (2015-2017) ($ millions)
    • CRISPR Therapeutics AG
      • Table CRISPR Therapeutics Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table CRISPR (2015-2017) ($ thousand)
    • CSL Behring
      • Table CSL Behring Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table CSL Behring (2015-2017) ($ millions)
    • Dr. Reddy's Laboratories Limited
      • Table Dr Reddy's Laboratories Corporate Summary
      • Company Overview
      • Company Financials
        • Table Dr Reddy's Laboratories (2015-2017) ($ millions)
    • Eli Lilly & Co
      • Table Eli Lilly Corporate Summary
      • Company Overview
        • Table Eli Lilly Regional Breakdown %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Eli Lilly (2015-2017) ($ millions)
    • Enzo Biochem, Inc
      • Table Enzo Biochem Corporate Summary
      • Company Overview
      • Company Financials
        • Table Enzo Biochem (2014-2017) ($ thousands)
    • Evotec AG
      • Table Evotec AG Corporate Summary
      • Company Overview
        • Table Evotec Regional Breakdown by %
        • Table Selected Corporate Developments
      • Company Financials
        • Table Evotec (2015-2017) ($ Thousands)
    • Exelixis
      • Table Exelixis Corporate Summary
      • Company Overview
        • Table Exelixis Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Exelixis (2015-2017) ($ thousands)
    • Genmab
      • Table Genmab Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Genmab (2015-2017) ($ thousands)
    • Gilead Sciences
      • Table Gilead Sciences Corporate Summary
      • Company Overview
        • Table Gilead Sciences Regional Breakdown by %
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Gilead (2015-2017) ($ millions)
    • GlaxoSmithKline
      • Table GlaxoSmithKline Corporate Summary
      • Company Overview
        • Table GSK Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table GSK (2015-2017) ($ millions)
    • Grifols International S.A.
      • Table Grifols International S.A. Corporate Summary
      • Company Overview
        • Table Grifols Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Corporate Development
      • Company Financials
        • Table Grifols (2015-2017) ($ millions)
    • Guardant Health
      • Table Guardant Health Corporate Summary
      • Company Overview
    • llumina
      • Table Illumina Corporate Summary
      • Company Overview
      • Company Financials
        • Table Illumina (2015-2017) ($ millions)
    • Incyte Corporation
      • Table Incyte Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Development
      • Company Financials
        • Table Incyte (2015-2017) ($ millions)
    • Johnson & Johnson
      • Table Johnson & Johnson Corporate Summary
      • Company Overview
        • Table J&J Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table J&J (2015-2017) ($ millions)
    • Merck & Co, Inc.
      • Table Merck Corporate Summary
      • Company Overview
        • Table Merck Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Merck (2015-2017) ($ millions)
    • Mylan
      • Table Mylan Corporate Summary
      • Company Overview
        • Table Mylan Regional Breakdown by %
      • Company Financials
        • Table Mylan (2015-2017) ($ millions)
    • Myriad Genetics
      • Table Myriad Genetics Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table Myriad (2015-2017) ($ millions)
    • Novartis International AG
      • Table Novartis Corporate Summary
      • Company Overview
        • Table Novartis Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Novartis (2015-2017) ($ millions)
    • Novo Nordisk A/S
      • Table Novo Nordisk Corporate Summary
      • Company Overview
        • Table Novo Nordisk Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table Novo Nordisk (2015-2017) ($ millions)
    • Organogenesis
      • Table Organogenesis Corporate Summary
      • Company Overview
    • Oxford Nanopore Technologies
      • Table Oxford Nanopore Technologies Corporate Summary
      • Company Overview
    • Perkin Elmer, Inc
      • Table Perkin Elmer Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table PerkinElmer (2015-2017) ($ millions)
    • Pfizer
      • Table Pfizer Corporate Summary
      • Company Overview
        • Table Pfizer Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Pfizer (2015-2017) ($ millions)
    • Precision BioSciences Inc
      • Table Precision BioSciences Corporate Summary
      • Company Overview
    • QIAGEN N.V.
      • Table QIAGEN Corporate Summary
      • Company Overview
        • Table QIAGEN Regional Breakdown by %
        • Table Selected Corporate Developments
      • Company Financials
        • Table QIAGEN (2015-2017) ($ millions)
    • Regeneron Pharmaceuticals
      • Table Regeneron Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Regeneron (2015-2017) ($ millions)
    • Roche Ltd.
      • Table Roche Corporate Summary
      • Company Overview
        • Table Roche Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table Roche (2015-2017) ($ millions)
    • Sanofi
      • Table Sanofi Corporate Summary
      • Company Overview
        • Table Sanofi Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Sanofi (2015-2017) ($ millions)
    • Seattle Genetics, Inc
      • Table Seattle Genetics Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Seattle Genetics (2015-2017) ($ millions)
    • Shire
      • Table Shire Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Development
      • Company Financials
        • Table Shire (2015-2017) ($ millions)
    • Takeda
      • Table Takeda Corporate Summary
      • Company Overview
        • Table Takeda Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Takeda (2015-2017) ($ millions)
    • Teva Pharmaceutical Industries, Ltd.
      • Table Teva Corporate Summary
      • Company Overview
        • Table Teva Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Teva (2015-2017) ($ millions)
    • Thermo Fisher Scientific, Inc
      • Table Thermo Fisher Scientific Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table Thermo Fisher Scientific (2015-2017) ($ millions)
    • UCB S.A.
      • Table UCB Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table UCB (2015-2017) ($ millions)
    • United Therapeutics Corporation
      • Table United Therapeutics Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table United Therapeutics (2015-2017) ($ millions)
    • Waters Corporation
      • Table Waters Corporate Summary
      • Company Overview
        • Table Waters Regional Breakdown by %
      • Company Financials
        • Table Waters (2015-2017) ($ millions)

50 Key Biopharmaceutical and Biotechnology Companies

Biopharmaceutical companies bring to market products that hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products.

50 Key Biopharmaceutical and Biotechnology Companies is a comprehensive look at the top 50 companies that are shaping the biotherapeutics market in 2017 and beyond. The top 50 companies in this report were chosen for a variety of reasons, including sales of marketed biopharmaceutical products, innovation in biotherapeutics, and unique additions to the market, either marketed products or products in development.

50 Key Biopharmaceutical and Biotechnology Companies profiles the market leaders in-depth, presenting detailed information about each company, including:

  • a Corporate Summary
  • Selected Biopharmaceutical Products
  • Biopharmaceuticals in Development
  • Selected Corporate Developments
  • Company Financials
  • Regional Revenue Breakdown by Percentage (%)
This report includes profiles of large traditional pharma powerhouses such as Pfizer, Novartis, Roche, Merck, GSK, Bristol-Myers Squibb, Bayer, and others; but it also includes smaller niche companies such as Genmab, Seattle Genetics, etc. In addition, it includes leading biopharmaceuticals such as Amgen and Biogen, and leading biotech companies such as Qiagen, Alexion, Agilent, Waters Co and others.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;